+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Artificial Intelligence (AI) in Biopharmaceuticals Market Report 2023-2033

  • PDF Icon

    Report

  • 218 Pages
  • June 2023
  • Region: Global
  • Visiongain
  • ID: 5836015
Description Jump to:
The overall world revenue for AI in Biopharmaceutical Market, 2023 to 2033 in terms of value will surpass US$49.3 billion in 2023. The author predicts strong revenue growth through to 2033. This work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

The Artificial Intelligence (AI) in Biopharmaceuticals Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing collaborations among organizations towards drug development enabled by AI

There has been a significant shift in cutting-edge AI technologies at big pharmaceutical companies. Since 2015, there has been a clear change in the public's image of artificial intelligence, from skepticism to cautious interest to the realization that AI plays a vital role in the new "data-centric" model of innovation. This shift in perception was supported by a number of elements, including: - a flurry of research discoveries and proof-of-concept studies in a variety of AI application use cases; - a number of commercial successes and successfully attained milestones incorporating AI as a key component of research. For instance, in March 2023, Exscientia PLC announced collaboration with Charité - Universitätsmedizin Berlin (Germany) to adopt AI-driven precision medicine platform in haematological cancers. In February 2023, Verily, an Alphabet precision health company, and Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka) announced that they are collaborating on novel methods for clinical trials looking at therapies for individuals with Major Depressive Disorder (MDD).

Developing interoperability systems is a challenging factor for the market

The capacity of systems and gadgets to communicate and decipher shared data through wired and wireless networks is referred to as interoperability. For all parties involved in the health care ecosystem, including biopharma businesses, it poses a serious challenge. The majority of biopharmaceutical businesses operate across many geographies with numerous diverse IT systems and require access to information from a wide range of IT systems used by healthcare organisations and other partners. The capacity to establish connectivity and communication between devices and IT systems, as well as between data and workflows, is necessary for interoperability. This is done by using consensus standards and protocols to enable secure and transparent data exchange.

The entire biopharma value chain must be improved through the development of interoperable technologies, especially in the area of patient data sharing with consent. Among many other uses, interoperability can assist businesses in communicating with clinicians and patients more effectively, enhancing the supply chain's ability to track and trace items, enhancing clinical decision support, locating patients, and enhancing drug adherence. To increase workflow efficiency and performance and to eliminate siloes behaviour, interoperability is required.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the AI in Biopharmaceutical market evolving?
  • What is driving and restraining the AI in Biopharmaceutical market?
  • How will each AI in Biopharmaceutical submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each AI in Biopharmaceutical submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading AI in Biopharmaceutical markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the AI in Biopharmaceutical projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of AI in Biopharmaceutical projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the AI in Biopharmaceutical market?
  • Where is the AI in Biopharmaceutical market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the AI in Biopharmaceutical market today, and over the next 10 years:

  • The 218-page report provides 90 tables and 137 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the AI in Biopharmaceutical market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, this new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising AI in Biopharmaceutical prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company.

Segments Covered in the Report

Technology Outlook

  • Deep Learning
  • NLP
  • Image Processing
  • Other Technologies

Application

  • Business Process & Supply Chain
  • Drug Discovery
  • Medical Imaging & Diagnostics
  • Precision Medicine

End-users

  • Manufacturers
  • Contract Research Organizations
  • Academic & Government Research Institutes
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 17 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA
The report also includes profiles and for some of the leading companies in the AI in Biopharmaceutical Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth

  • Alphabet Inc.
  • Amgen Inc.
  • ConcertAI
  • Exscientia
  • Insilico Medicine
  • Merative (IBM)
  • Microsoft
  • NVIDIA Corporation
  • Schrödinger, Inc.
  • Tencent

How will the AI in Biopharmaceutical Market, 2023 to 2033 report help you?

In summary, this 210+ page report provides you with the following knowledge:
  • Revenue forecasts to 2033 for AI in Biopharmaceutical Market, 2023 to 2033 Market, with forecasts for technology, application, and end-users, each forecast at a global and regional level - discover the industry’s prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 17 key national markets - See forecasts for the AI in Biopharmaceutical Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 10 of the major companies involved in the AI in Biopharmaceutical Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how the work could benefit your research, analyses, and decisions. The study is for everybody needing commercial analyses for the AI in Biopharmaceutical Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Automation in Drug Discovery and development
3.2.1.2 Better data analysis and pattern recognition in biopharma with AI to drive the technology adoption
3.2.1.3 Patent expiry to create opportunity for AI-driven development
3.2.2 Market Restraining Factors
3.2.2.1 Developing interoperability systems is a challenging factor for the market
3.2.2.2 Data Privacy and security
3.2.3 Market Opportunities
3.2.3.1 Increasing collaborations among organizations towards drug development enabled by AI
3.2.3.2 India to be one of the most lucrative countries for investment in biotechnologies
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 Artificial Intelligence in Biopharmaceutical Market Analysis by Technology
4.1 Key Findings
4.2 Technology Segment: Market Attractiveness Index
4.3 Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Technology
4.4 Deep Learning
4.4.1 Market Size by Region, 2023-2033 (US$ Million)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Natural Language Processing (NLP)
4.5.1 Market Size by Region, 2023-2033 (US$ Million)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.6 Image Processing
4.6.1 Market Size by Region, 2023-2033 (US$ Million)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.7 Other Technologies
4.7.1 Market Size by Region, 2023-2033 (US$ Million)
4.7.2 Market Share by Region, 2023 & 2033 (%)
5 Artificial Intelligence in Biopharmaceutical Market Analysis by Application
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Application
5.4 Business Process & Supply Chain
5.4.1 Market Size by Region, 2023-2033 (US$ Million)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Drug Discovery
5.5.1 Market Size by Region, 2023-2033 (US$ Million)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Medical Imaging & Diagnostics
5.6.1 Market Size by Region, 2023-2033 (US$ Million)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Precision Medicine
5.7.1 Market Size by Region, 2023-2033 (US$ Million)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Research
5.8.1 Market Size by Region, 2023-2033 (US$ Million)
5.8.2 Market Share by Region, 2023 & 2033 (%)
6 Artificial Intelligence in Biopharmaceutical Market Analysis by End-users
6.1 Key Findings
6.2 End-users Segment: Market Attractiveness Index
6.3 Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by End-users
6.4 Manufacturers
6.4.1 Market Size by Region, 2023-2033 (US$ Million)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Contract Research Organizations (CROs)
6.5.1 Market Size by Region, 2023-2033 (US$ Million)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Academic & Government Research Institutes
6.6.1 Market Size by Region, 2023-2033 (US$ Million)
6.6.2 Market Share by Region, 2023 & 2033 (%)
7 Artificial Intelligence in Biopharmaceutical Market Analysis by Region
7.1 Key Findings
7.2 Regional Market Size Estimation and Forecast
8 North America Artificial Intelligence in Biopharmaceutical Market Analysis
8.1 Key Findings
8.2 North America Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
8.3 North America Artificial Intelligence in Biopharmaceutical Market by Country, 2023, 2028 & 2033 (US$ Million)
8.4 North America Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Country
8.5 North America Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Technology
8.6 North America Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Application
8.7 North America Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by End-users
8.8 U.S. Artificial Intelligence in Biopharmaceutical Market Analysis
8.9 Canada Artificial Intelligence in Biopharmaceutical Market Analysis
9 Europe Artificial Intelligence in Biopharmaceutical Market Analysis
9.1 Key Findings
9.2 Europe Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
9.3 Europe Artificial Intelligence in Biopharmaceutical Market by Country, 2023, 2028 & 2033 (US$ Million)
9.4 Europe Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Country
9.5 Europe Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Technology
9.6 Europe Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Application
9.7 Europe Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by End-users
9.8 Germany Artificial Intelligence in Biopharmaceutical Market Analysis
9.9 France Artificial Intelligence in Biopharmaceutical Market Analysis
9.10 U.K. Artificial Intelligence in Biopharmaceutical Market Analysis
9.11 Italy Artificial Intelligence in Biopharmaceutical Market Analysis
9.12 Spain Artificial Intelligence in Biopharmaceutical Market Analysis
9.13 Russia Artificial Intelligence in Biopharmaceutical Market Analysis
9.14 Rest of Europe Artificial Intelligence in Biopharmaceutical Market Analysis
10 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Analysis
10.1 Key Findings
10.2 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
10.3 Asia Pacific Artificial Intelligence in Biopharmaceutical Market by Country, 2023, 2028 & 2033 (US$ Million)
10.4 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Country
10.5 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Technology
10.6 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Application
10.7 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by End-users
10.8 Japan Artificial Intelligence in Biopharmaceutical Market Analysis
10.9 China Artificial Intelligence in Biopharmaceutical Market Analysis
10.10 India Artificial Intelligence in Biopharmaceutical Market Analysis
10.11 Australia Artificial Intelligence in Biopharmaceutical Market Analysis
10.12 South Korea Artificial Intelligence in Biopharmaceutical Market Analysis
10.13 Rest of Asia-Pacific Artificial Intelligence in Biopharmaceutical Market Analysis
11 Latin America Artificial Intelligence in Biopharmaceutical Market Analysis
11.1 Key Findings
11.2 Latin America Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
11.3 Latin America Artificial Intelligence in Biopharmaceutical Market by Country, 2023, 2028 & 2033 (US$ Million)
11.4 Latin America Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Country
11.5 Latin America Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Technology
11.6 Latin America Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Application
11.7 Latin America Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by End-users
11.8 Brazil Artificial Intelligence in Biopharmaceutical Market Analysis
11.9 Mexico Artificial Intelligence in Biopharmaceutical Market Analysis
11.10 Rest of Latin America Artificial Intelligence in Biopharmaceutical Market Analysis
12 MEA Artificial Intelligence in Biopharmaceutical
12.1 Key Findings
12.2 MEA Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
12.3 MEA Artificial Intelligence in Biopharmaceutical Market by Country, 2023, 2028 & 2033 (US$ Million)
12.4 MEA Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Country
12.5 MEA Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Technology
12.6 MEA Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by Application
12.7 MEA Artificial Intelligence in Biopharmaceutical Market Size Estimation and Forecast by End-users
12.8 GCC Artificial Intelligence in Biopharmaceutical Market Analysis
12.9 South Africa Artificial Intelligence in Biopharmaceutical Market Analysis
12.10 Rest of MEA Artificial Intelligence in Biopharmaceutical Market Analysis
13 Company Profiles
13.1 Competitive Landscape, 2022
13.2 Strategic Outlook
13.3 Microsoft
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2017-2022
13.3.3.2 R&D, 2017-2022
13.3.3.3 Regional Market Shares, 2022
13.3.4 Product & Solution Benchmarking
13.3.5 Strategic Outlook
13.4 NVIDIA Corporation
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2017-2022
13.4.3.2 R&D, 2017-2022
13.4.3.3 Regional Market Shares, 2022
13.4.4 Solution Benchmarking
13.4.5 Strategic Outlook
13.5 Alphabet Inc.
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis
13.5.3.1 Net Revenue, 2017-2022
13.5.3.2 R&D, 2017-2022
13.5.3.3 Regional Market Shares, 2022
13.5.4 Solution Benchmarking
13.5.5 Strategic Outlook
13.6 Amgen Inc.
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Analysis
13.6.3.1 Net Revenue, 2017-2022
13.6.3.2 R&D, 2017-2022
13.6.3.3 Regional Market Shares, 2022
13.6.4 Solution Benchmarking
13.6.5 Strategic Outlook
13.7 Merative ( previously IBM)
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Analysis
13.7.3.1 Net Revenue, 2017-2022
13.7.3.2 R&D, 2017-2022
13.7.3.3 Regional Market Shares, 2022
13.7.4 Solution Benchmarking
13.7.5 Strategic Outlook
13.8 Tencent
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Analysis
13.8.3.1 Net Revenue, 2018-2022
13.8.4 Solution Benchmarking
13.9 Exscientia PLC
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Analysis
13.9.3.1 Net Revenue, 2020-2022
13.9.3.2 Regional Market Shares, 2021
13.9.4 Solution Benchmarking
13.9.5 Strategic Outlook
13.10 Schrödinger, Inc.
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Analysis
13.10.3.1 Net Revenue, 2018-2022
13.10.3.2 R&D, 2017-2022
13.10.4 Solution Benchmarking
13.10.5 Strategic Outlook
13.11 Insilico Medicine
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Solution Benchmarking
13.11.4 Strategic Outlook
13.12 ConcertAI
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Solution Benchmarking
13.12.4 Strategic Outlook
14 Conclusion and Recommendations
14.1 Concluding Remarks from
14.2 Recommendations for Market Players
List of Tables
Table 1 Artificial Intelligence in Biopharmaceutical Market Snapshot, 2023 & 2033 (US$ Million, CAGR %)
Table 2 Biotechnology R&D Expenditures in the sector by OECD countries, 2016-2020
Table 3 Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 4 Deep Learning Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 5 NLP Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 6 Image Processing Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 7 Other Technologies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 Business Process & Supply Chain Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Drug Discovery Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 11 Medical Imaging & Diagnostics Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 12 Precision Medicine Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Research Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 15 Manufacturers Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 CROs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 Academic & Government Research Institutes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 Artificial Intelligence in Biopharmaceutical Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 North America Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 20 North America Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 North America Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 North America Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 Top U.S. Biotech Funding in 2022
Table 24 U.S. Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 25 Canada Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 26 Europe Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 27 Europe Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 Europe Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 29 Europe Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 Germany Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 31 France Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 32 U.K. Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 33 Italy Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 34 Spain Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Russia Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 Rest of Europe Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 37 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 Japan Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 42 China Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 43 India Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 44 Australia Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 South Korea Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 Rest of Asia-Pacific Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 47 Latin America Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 Latin America Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 Latin America Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Latin America Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 Brazil Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 Mexico Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 Rest of Latin America Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 MEA Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 MEA Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 MEA Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 MEA Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 GCC Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 South Africa Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 Rest of MEA Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 61 Top Company Share Analysis, 2022
Table 62 Strategic Outlook
Table 63 Microsoft: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 64 Microsoft: Product & Solution Benchmarking
Table 65 Microsoft: Strategic Outlook
Table 66 NVIDIA Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 67 NVIDIA Corporation: Solution Benchmarking
Table 68 NVIDIA Corporation: Strategic Outlook
Table 69 Alphabet Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 70 Alphabet Inc.: Solution Benchmarking
Table 71 Alphabet Inc.: Strategic Outlook
Table 72 Amgen Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 73 Amgen Inc.: Solution Benchmarking
Table 74 Amgen: Strategic Outlook
Table 75 Merative (IBM): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 76 Merative (IBM): Solution Benchmarking
Table 77 Merative (IBM): Strategic Outlook
Table 78 Tencent.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 Tencent: Solution Benchmarking
Table 80 Exscientia PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 Exscientia PLC: Solution Benchmarking
Table 82 Exscientia PLC: Strategic Outlook
Table 83 Schrödinger, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 Schrödinger, Inc: Solution Benchmarking
Table 85 Schrödinger, Inc: Strategic Outlook
Table 86 Insilico Medicine: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 Insilico Medicine: Solution Benchmarking
Table 88 Insilico Medicine: Strategic Outlook
Table 89 ConcertAI: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 ConcertAI: Solution Benchmarking
Table 91 ConcertAI: Strategic Outlook
List of Figures
Figure 1 Artificial Intelligence in Biopharmaceutical Market Segmentation
Figure 2 Artificial Intelligence in Biopharmaceutical Market by Technology: Market Attractiveness Index
Figure 3 Artificial Intelligence in Biopharmaceutical Market by Application: Market Attractiveness Index
Figure 4 Artificial Intelligence in Biopharmaceutical Market by End-users: Market Attractiveness Index
Figure 5 Artificial Intelligence in Biopharmaceutical Market Attractiveness Index by Region
Figure 6 Artificial Intelligence in Biopharmaceutical Market Dynamics
Figure 7 Global AI in Healthcare Market Trend, 2022 - 2030
Figure 8 Artificial Intelligence in Biopharmaceutical Market: Porter’s Five Forces Analysis
Figure 9 Artificial Intelligence in Biopharmaceutical Market: PEST Analysis
Figure 10 Artificial Intelligence in Biopharmaceutical Market by Technology: Market Attractiveness Index
Figure 11 Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 12 Artificial Intelligence in Biopharmaceutical Market Share Forecast by Technology, 2023, 2028, 2033 (%)
Figure 13 Deep Learning Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 14 Deep Learning Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 15 NLP Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 16 NLP Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 17 Image Processing Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 18 Image Processing Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Other Technologies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 20 Other Technologies Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Artificial Intelligence in Biopharmaceutical Market by Application: Market Attractiveness Index
Figure 22 Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 23 Artificial Intelligence in Biopharmaceutical Market Share Forecast by Application, 2023, 2028, 2033 (%)
Figure 24 Business Process & Supply Chain Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 25 Business Process & Supply Chain Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 26 Drug Discovery Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 27 Drug Discovery Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Medical Imaging & Diagnostics Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 29 NLP Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Precision Medicine Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 31 Precision Medicine Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Research Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 33 Research Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 Artificial Intelligence in Biopharmaceutical Market by End-users: Market Attractiveness Index
Figure 35 Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 36 Artificial Intelligence in Biopharmaceutical Market Share Forecast by End-users, 2023, 2028, 2033 (%)
Figure 37 Manufacturers Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 38 Manufacturers Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 39 CROs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 40 CROs Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 41 Academic & Government Research Institutes Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 42 Academic & Government Research Institutes Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Artificial Intelligence in Biopharmaceutical Market Forecast by Region 2023 and 2033 (Revenue, CAGR %)
Figure 44 Artificial Intelligence in Biopharmaceutical Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 45 Artificial Intelligence in Biopharmaceutical Market by Region, 2023-2033 (US$ Million, AGR %)
Figure 46 North America Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
Figure 47 North America Artificial Intelligence in Biopharmaceutical Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 48 North America Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 49 North America Artificial Intelligence in Biopharmaceutical Market Share Forecast by Country, 2023 & 2033 (%)
Figure 50 North America Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 51 North America Artificial Intelligence in Biopharmaceutical Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 52 North America Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 53 North America Artificial Intelligence in Biopharmaceutical Market Share Forecast by Application, 2023 & 2033 (%)
Figure 54 North America Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 55 North America Artificial Intelligence in Biopharmaceutical Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 56 U.S. Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 57 Canada Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 58 Europe Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
Figure 59 Europe Artificial Intelligence in Biopharmaceutical Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 60 Europe Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 61 Europe Artificial Intelligence in Biopharmaceutical Market Share Forecast by Country, 2023 & 2033 (%)
Figure 62 Europe Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 63 Europe Artificial Intelligence in Biopharmaceutical Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 64 Europe Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 65 Europe Artificial Intelligence in Biopharmaceutical Market Share Forecast by Application, 2023 & 2033 (%)
Figure 66 Europe Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 67 Europe Artificial Intelligence in Biopharmaceutical Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 68 Germany Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 69 France Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 70 U.K. Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 71 Italy Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 72 Spain Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 73 Russia Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 74 Rest of Europe Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 75 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
Figure 76 Asia Pacific Artificial Intelligence in Biopharmaceutical Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 77 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 78 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Share Forecast by Country, 2023 & 2033 (%)
Figure 79 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 80 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 81 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 82 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Share Forecast by Application, 2023 & 2033 (%)
Figure 83 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 84 Asia Pacific Artificial Intelligence in Biopharmaceutical Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 85 Japan Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 86 China Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 87 India Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 88 Australia Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 89 South Korea Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 90 Rest of Asia-Pacific Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 91 Latin America Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
Figure 92 Latin America Artificial Intelligence in Biopharmaceutical Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 93 Latin America Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 94 Latin America Artificial Intelligence in Biopharmaceutical Market Share Forecast by Country, 2023 & 2033 (%)
Figure 95 Latin America Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 96 Latin America Artificial Intelligence in Biopharmaceutical Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 97 Latin America Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 98 Latin America Artificial Intelligence in Biopharmaceutical Market Share Forecast by Application, 2023 & 2033 (%)
Figure 99 Latin America Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 100 Latin America Artificial Intelligence in Biopharmaceutical Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 101 Brazil Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 102 Mexico Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 103 Rest of Latin America Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 104 MEA Artificial Intelligence in Biopharmaceutical Market Attractiveness Index
Figure 105 MEA Artificial Intelligence in Biopharmaceutical Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 106 MEA Artificial Intelligence in Biopharmaceutical Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 107 MEA Artificial Intelligence in Biopharmaceutical Market Share Forecast by Country, 2023 & 2033 (%)
Figure 108 MEA Artificial Intelligence in Biopharmaceutical Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 109 MEA Artificial Intelligence in Biopharmaceutical Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 110 MEA Artificial Intelligence in Biopharmaceutical Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 111 MEA Artificial Intelligence in Biopharmaceutical Market Share Forecast by Application, 2023 & 2033 (%)
Figure 112 MEA Artificial Intelligence in Biopharmaceutical Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 113 MEA Artificial Intelligence in Biopharmaceutical Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 114 GCC Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 115 South Africa Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 116 Rest of MEA Artificial Intelligence in Biopharmaceutical Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 117 Artificial Intelligence in Biopharmaceutical Market: Company Share, 2022
Figure 118 Microsoft: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 119 Microsoft: R&D, 2017-2022 (US$ Billion, AGR%)
Figure 120 Microsoft: Regional Market Shares, 2022
Figure 121 NVIDIA Corporation: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 122 NVIDIA Corporation: R&D, 2017-2022 (US$ Billion, AGR%)
Figure 123 NVIDIA Corporation: Regional Market Shares, 2022
Figure 124 Alphabet Inc.: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 125 Alphabet Inc.: R&D, 2017-2022 (US$ Billion, AGR%)
Figure 126 Alphabet Inc.: Regional Market Shares, 2022
Figure 127 Amega Inc.: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 128 Amgen Inc.: R&D, 2017-2022 (US$ Billion, AGR%)
Figure 129 Amgen Inc.: Regional Market Shares, 2022
Figure 130 Merative (IBM): Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 131 Merative (IBM): R&D, 2017-2022 (US$ Billion, AGR%)
Figure 132 Merative (IBM): Regional Market Shares, 2022
Figure 133 Tencent.: Net Revenue, 2018-2022 (US$ Billion, AGR%)
Figure 134 Exscientia PLC: Net Revenue, 2020-2022 (US$ Million, AGR%)
Figure 135 Exscientia PLC.: Regional Market Shares, 2021
Figure 136 Schrödinger, Inc.: Net Revenue, 2018-2022 (US$ Million, AGR%)
Figure 137 Schrödinger, Inc: R&D, 2018-2022 (US$ Billion, AGR%)

Companies Mentioned

  • Alphabet Inc.
  • Amgen Inc.
  • ConcertAI
  • Exscientia
  • Insilico Medicine
  • Merative (IBM)
  • Microsoft
  • NVIDIA Corporation
  • Schrödinger, Inc.
  • Tencent
  • AIBrain
  • Almirall
  • Amazon
  • Apple
  • AstraZeneca
  • Atomwise
  • Babylon Health
  • Bayer
  • Bio-Manguinhos
  • Bio-Rio
  • Biotecnol
  • BioXcel Therapeutics
  • BrainOS
  • Bristol-Myers Squibb
  • Cleveland Clinic
  • Collaborations Pharmaceuticals, Inc.
  • Deep 6 AI
  • DeepL
  • DeepMind Health
  • Deepomatic
  • Ferrer
  • Generate Biomedicine
  • GlaxoSmithKline
  • Grifols
  • MediChain
  • Merck & Co.
  • Novartis
  • Novo Nordisk A/S
  • NuMedii
  • Otsuka Pharmaceutical Development & Commercialization, Inc.
  • Oxford Nanopore
  • PubMed
  • Sanofi
  • Siemens Healthineers
  • Snips
  • Teva Pharmaceuticals
  • Usynova
  • VinBrain
  • Ayushman Bharat Digital Mission (ABDM)
  • Ayushman Bharat Health Account (ABHA)
  • Imperial College London
  • Ministry of Health, Labor and Welfare (MHLW)
  • National Autonomous University of Mexico (UNAM)
  • National Health Authority (NHA)
  • National Health System (SNS)
  • National Institute for Health Research (NIHR)
  • National Institute of Biotechnology and Applied Sciences (INBIOTEC)
  • National Institute of Health Carlos III (ISCIII)
  • National Institutes of Health (NIH)
  • NC State University
  • Organisation for Economic Co-operation and Development (OECD)
  • South African National Bioinformatics Institute (SANBI)
  • United States Department of Health and Human Services
  • University of Oxford
  • University of the Witwatersrand (Wits)

Related Topics

Related Reports

Artificial Intelligence Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis - Product Image

Artificial Intelligence Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis

  • Report
  • 250 Pages
  • Global
From
United States Artificial Intelligence Market, Competition, Forecast & Opportunities, 2028 - Product Image

United States Artificial Intelligence Market, Competition, Forecast & Opportunities, 2028

  • Report
  • 89 Pages
  • United States
From
North America Artificial Intelligence Market, By Country, Competition, Forecast, and Opportunities, 2019-2029F - Product Image

North America Artificial Intelligence Market, By Country, Competition, Forecast, and Opportunities, 2019-2029F

  • Report
  • 132 Pages
  • North America
From
Artificial Intelligence for IT Operations Market by Component, Function, Deployment, Industry - Global Forecast 2025-2030 - Product Image

Artificial Intelligence for IT Operations Market by Component, Function, Deployment, Industry - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Bioprocess Validation Market Report 2023-2033 - Product Image

Bioprocess Validation Market Report 2023-2033

  • Report
  • 315 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.